Clinical Trials Browser

Phase 2 × Primary Myelofibrosis × LCL161 × Clear all

NCT02098161 2023-06-06

LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis

Phase 2 Completed

50 enrolled 11 charts

Polycythemia Vera, Primary Myelofibrosis